EXPLORE A TOPIC
Research and resources to help you take a closer look.
The resource library
5 resourcesThe rat wound-chamber model is a controlled in vivo system for quantifying extracellular matrix accumulation and tissue repair processes in response to GHK-Cu. This article explains the methodology, measured endpoints, and limitations of this model, focusing on evidence from a key cited study.
Scratch closure in an in vitro Epitalon-treated retinal pigment epithelial cell model demonstrates enhanced wound healing but does not provide evidence of restored vision. This article examines the experimental context, findings, and limitations of such cell-based assays, clarifying why these results cannot be extrapolated to visual function or clinical outcomes.
Gene-expression changes and collagen accumulation are distinct endpoints in GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) research. This article examines why gene expression data do not directly equate to measurable collagen deposition, drawing on in vitro, animal, and gene array studies. Evidence limitations and mechanistic uncertainties are discussed.
Rat wound studies show that GHK-Cu (glycyl-L-histidyl-L-lysine-copper) can stimulate connective tissue accumulation, including collagen and glycosaminoglycans, in vivo. However, these findings are limited to animal models and cannot be directly translated to human outcomes or clinical recommendations. The mechanisms and potential applications in humans remain uncertain and require further research.
GHK-Cu (glycyl-L-histidyl-L-lysine-copper) research demonstrates its ability to stimulate extracellular matrix (ECM) accumulation in animal models and modulate gene expression in cell lines. However, these findings are limited to preclinical contexts, and there is no direct evidence supporting the benefit or safety of retail GHK-Cu products, such as GHKCU 100 MG, in humans. All research products are for laboratory use only.
